IL1RL1 and cancer: IL1RL1 was also a major impediment to anti-tumor immune responses, and a study by Sun et al. noted that high expression of IL1RL1 signaling in Treg promoted fibrosis and immunosuppression in cancer-associated fibroblasts [36].